Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma.

Jo T, Noguchi K, Sakai T, Umemoto K, Yamaguchi K, Ikegami S, Baba R, Inoue T, Irie S, Matsuo M, Sawayama Y, Taguchi J, Abe K, Shigematsu K, Miyazaki Y

Open source

DOI: 10.3389/fimmu.2026.1919613
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1919613,
  title = {Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma.},
  author = {Jo T and Noguchi K and Sakai T and Umemoto K and Yamaguchi K and Ikegami S and Baba R and Inoue T and Irie S and Matsuo M and Sawayama Y and Taguchi J and Abe K and Shigematsu K and Miyazaki Y},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1919613},
  url = {https://doi.org/10.3389/fimmu.2026.1919613}
}

RIS

TY  - JOUR
TI  - Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma.
AU  - Jo T
AU  - Noguchi K
AU  - Sakai T
AU  - Umemoto K
AU  - Yamaguchi K
AU  - Ikegami S
AU  - Baba R
AU  - Inoue T
AU  - Irie S
AU  - Matsuo M
AU  - Sawayama Y
AU  - Taguchi J
AU  - Abe K
AU  - Shigematsu K
AU  - Miyazaki Y
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1919613
UR  - https://doi.org/10.3389/fimmu.2026.1919613
ER  -

APA

T, J., K, N., T, S., K, U., K, Y., S, I., R, B., T, I., S, I., M, M., Y, S., J, T., K, A., K, S., & Y, M. (2026). Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1919613

Source records

pubmed · retrieved 2026-09-25T21:58:14.491Z